Veterinary Health Company Pops On Acquisition Update

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, July 6, 2022

An Ann Arbor-based veterinary health company that is no stranger to making headlines did it yet again after the company announced that the acquisition of the assets of Revo Squared LLC was recently completed. This announcement sent shares of Zomedica Corp (NYSE American:ZOM) higher as people are anticipating great things to come out of the acquisition, including the use of Revo's innovative MicroView digital cytology platform.

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

Traders were bullish on the news as shares climbed up to $0.256/share (+16.36%) at the session high. This move could be an indication of things to come as it appears some support may have been found for this stock.

Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.